Activities of Cethromycin and Telithromycin against Recent North American Isolates of Streptococcus pneumoniae
Open Access
- 1 February 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (2) , 605-607
- https://doi.org/10.1128/aac.48.2.605-607.2004
Abstract
The in vitro activities of two investigational ketolides, cethromycin (formerly ABT-773) and telithromycin, were determined for a selected group of 312 Streptococcus pneumoniae isolates from a national surveillance program. The MIC of cethromycin at which 50% of the isolates were inhibited was 0.008 μg/ml, and the MIC at which 90% of the isolates were inhibited was 0.06 μg/ml; the corresponding values for telithromycin were ≤0.015 and 0.25 μg/ml, respectively. For six quinupristin-dalfopristin-resistant strains, the cethromycin MICs were 0.25 to 16 μg/ml and the telithromycin MICs were 1 to 4 μg/ml. However, there was only 0.3% resistance to telithromycin.Keywords
This publication has 20 references indexed in Scilit:
- Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 StudyAntimicrobial Agents and Chemotherapy, 2003
- In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or MacrolidesAntimicrobial Agents and Chemotherapy, 2003
- Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 2002
- Resistance to Levofloxacin and Failure of Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and StaphylococciAntimicrobial Agents and Chemotherapy, 2002
- Emergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Comparative In Vitro Activity of ABT-773, a Novel Antibacterial KetolideAntimicrobial Agents and Chemotherapy, 2001
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98Emerging Infectious Diseases, 1999
- The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance SystemThe Journal of Infectious Diseases, 1996